Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Ligand Pharmaceuticals (LGND) over the last 16 years, with Dec 2024 value amounting to -$0.22.

  • Ligand Pharmaceuticals' EPS (Weighted Average and Diluted) rose 1556.41% to $5.68 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.03, marking a year-over-year decrease of 19.12%. This contributed to the annual value of -$0.22 for FY2024, which is 107.26% down from last year.
  • According to the latest figures from FY2024, Ligand Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.22, which was down 107.26% from $3.03 recorded in FY2023.
  • Ligand Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $4.43 for FY2021, and its period low was -$1.98 during FY2022.
  • Over the past 3 years, Ligand Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.22 (recorded in 2024), while the average stood at $0.28.
  • As far as peak fluctuations go, Ligand Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 1,035.90% in 2021, and later plummeted by 144.70% in 2022.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.39 in 2020, then soared by 1,035.90% to $4.43 in 2021, then slumped by 144.70% to -$1.98 in 2022, then spiked by 253.03% to $3.03 in 2023, then tumbled by 107.26% to -$0.22 in 2024.